ONABOTULINUMTOXINA REDUCES NOCTURNAL VOIDS AND IMPROVES QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS WITH NOCTURIA

被引：0
|
作者：
Dmochowski, R. [1 ]
Ginsberg, D. [2 ]
Parsons, M. [3 ]
Robinson, D. [4 ]
Magyar, A. [5 ]
Nicandro, J. [6 ]
Drake, M. [7 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] USC Inst Urol, Los Angeles, CA USA
[3] Birmingham Womens NHS Fdn, Birmingham, W Midlands, England
[4] Kings Coll Hosp NHS Fdn, London, England
[5] Allergen Inc, Bridgewater, NJ USA
[6] Allergen Inc, Irvine, CA USA
[7] Bristol Urol Inst, Bristol, Avon, England
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
PLACEBO-CONTROLLED TRIAL; URINARY-INCONTINENCE;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
165
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [1] ONABOTULINUMTOXINA IMPROVES SYMPTOMS OF OVERACTIVE BLADDER, INCLUDING NOCTURIA
    Nitti, Victor
    Dmochowski, Roger
    Sand, Peter
    Thompson, Catherine
    Yan, Xiaohong
    Herschorn, Sender
    [J]. NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 109 - 110
  • [2] ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Khullar, V.
    Sand, P.
    Parsons, M.
    Zhou, J.
    Globe, D.
    Nardo, C.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S13 - S14
  • [3] Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia
    Rackley, R
    Weiss, JP
    Rovner, ES
    Wang, JT
    Guan, ZH
    [J]. UROLOGY, 2006, 67 (04) : 731 - 736
  • [4] Nighttime dosing of tolterodine reduces overactive bladder-related nocturnal frequency in patients with overactive bladder and nocturia
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 62 - 62
  • [5] OnabotulinumtoxinA reduces urinary incontinence and urgency and improves quality of life in patients with overactive bladder regardless of incontinence severity at baseline
    Drake, M.
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    James, C.
    Magyar, A.
    Herschorn, S.
    [J]. BJU INTERNATIONAL, 2015, 115 : 40 - 40
  • [6] Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia - Comment
    Lemack, GE
    [J]. UROLOGY, 2006, 67 (04) : 736 - 736
  • [7] TREATMENT WITH ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES EPISODES OF URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME
    Sand, Peter
    Parsons, Matthew
    Zhou, Jihao
    Globe, Denise
    Nardo, Christopher
    Khullar, Vik
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 209 - 209
  • [8] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE
    Sand, P. K.
    Khalaf, K. M.
    Yan, X.
    Globe, D.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192
  • [9] Nocturnal polyuria versus overactive bladder in nocturia
    Weiss, JP
    Blaivas, JG
    [J]. UROLOGY, 2002, 60 (5A) : 28 - 32
  • [10] ONABOTULINUMTOXINA PROVIDES EARLY AND CONSISTENT IMPROVEMENTS IN OVERACTIVE BLADDER SYMPTOMS AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER
    McCammon, Kurt
    Kohan, Alfred
    Kaminetsky, Jed
    Gousse, Angelo
    Gruenenfelder, Jennifer
    Orejudos, Amelia
    Aboushwareb, Tamer
    MacDiarmid, Scott
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E510 - E510
12345